This company has been marked as potentially delisted and may not be actively trading. NYSE:GI EndoChoice (GI) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About EndoChoice Stock (NYSE:GI) 30 days 90 days 365 days Advanced Chart Get EndoChoice alerts:Sign Up Key Stats Today's Range$8.00▼$8.0050-Day Range N/A52-Week Range$3.64▼$9.47VolumeN/AAverage Volume131,115 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEndoChoice Holdings, Inc. is a medical device company. The Company is focused on designing and commercializing a platform of products and services for gastrointestinal (GI) caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems. The Company's products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The Company's imaging products include Fuse system, EndoCart, and Endoscope repair and maintenance. The Company's single-use therapeutic devices include Neptune injection needle, Boa polypectomy snare, Rescue retrieval devices, Blox bite block, TrapEase polyp traps, Hydra irrigation system, EndoGlide+, Compliance EndoKit, SafeStart, EndoKit, CinchPad and GI pathology. The Company serves over 2,500 GI departments that perform endoscopic procedures.Read More… Receive GI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EndoChoice and its competitors with MarketBeat's FREE daily newsletter. Email Address GI Stock News HeadlinesUsing Veterans Benefits to Pay for Grad SchoolOctober 25, 2024 | usnews.comFlexible Endoscopes Market Growth, Business Overview 2023, and Forecast to 2029 | Olympus, Fujifilm, HOYAMay 5, 2023 | marketwatch.comF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.May 28, 2025 | The Tomorrow Investor (Ad)Endoscopic Accessories Market Business Report [2023-2030]April 27, 2023 | marketwatch.comEndoscopic Accessories Market Global Analysis 2023-2030April 24, 2023 | marketwatch.comEndoscopic Accessories Market New Ready Report Analysis 2028March 29, 2023 | marketwatch.comBest Children's Hospitals for Gastroenterology & GI SurgeryMarch 18, 2023 | health.usnews.com2023 Flexible Endoscopes Market Largest Share and Growth Potential by 2026 | 94 PagesFebruary 27, 2023 | marketwatch.comSee More Headlines GI Stock Analysis - Frequently Asked Questions How were EndoChoice's earnings last quarter? EndoChoice Holdings Inc (NYSE:GI) issued its earnings results on Wednesday, May, 4th. The medical equipment provider reported ($0.68) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by $0.13. The firm's quarterly revenue was up 10.2% compared to the same quarter last year. When did EndoChoice IPO? EndoChoice (GI) raised $101 million in an IPO on Friday, June 5th 2015. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, BofA Merrill Lynch, William Blair and Stifel served as the underwriters for the IPO. What other stocks do shareholders of EndoChoice own? Based on aggregate information from My MarketBeat watchlists, some other companies that EndoChoice investors own include Cognyte Software (CGNT), Butterfly Network (BFLY), Coeur Mining (CDE), Denison Mines (DNN), DarioHealth (DRIO), CarParts.com (PRTS) and Air Canada (AC). Company Calendar Last Earnings5/04/2016Today5/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:GI CIK1623919 Webwww.endochoice.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSE:GI) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored“You all just got a lot richer”Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crash...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EndoChoice Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share EndoChoice With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.